Clinical Trial Update: Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intracavernosal injections of Botulinum Toxin Type A (50 and 100 units) for erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Benha University | Conditions: Erectile Dysfunction, Botulinum Toxin | Phase 2 | Status: COMPLETED